BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 28420927)

  • 1. In silico analysis of fragile histidine triad involved in regression of carcinoma.
    Rasheed MA; Tariq F; Afzal S; Mannanv S
    J Pak Med Assoc; 2017 Apr; 67(4):616-621. PubMed ID: 28420927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of fragile histidine triad protein in human hepatocellular carcinoma.
    Zhao P; Song X; Nin YY; Lu YL; Li XH
    World J Gastroenterol; 2003 Jun; 9(6):1216-9. PubMed ID: 12800227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and Prognostic Role of FHIT, Fibronectin, and PTEN in Hepatocellular Carcinoma.
    Zhang MJ; Yan Q; Zhang GL; Wie YH; Yuan WB; Xu W; Huang LF
    Clin Lab; 2016 Jul; 62(7):1255-1264. PubMed ID: 28164627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced Fhit expression is associated with mismatch repair deficiency in human advanced colorectal carcinoma.
    Andachi H; Yashima K; Koda M; Kawaguchi K; Kitamura A; Hosoda A; Kishimoto Y; Shiota G; Ito H; Makino M; Kaibara N; Kawasaki H; Murawaki Y
    Br J Cancer; 2002 Aug; 87(4):441-5. PubMed ID: 12177781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of fragile histidine triad in primary hepatocellular carcinoma and its relation with cell proliferation and apoptosis.
    Nan KJ; Ruan ZP; Jing Z; Qin HX; Wang HY; Guo H; Xu R
    World J Gastroenterol; 2005 Jan; 11(2):228-31. PubMed ID: 15633221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel proteins associated with hepatocellular carcinomas using protein microarrays.
    Tannapfel A; Anhalt K; Häusermann P; Sommerer F; Benicke M; Uhlmann D; Witzigmann H; Hauss J; Wittekind C
    J Pathol; 2003 Oct; 201(2):238-49. PubMed ID: 14517841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant methylation of Fragile Histidine Triad gene is associated with poor prognosis in early stage esophageal squamous cell carcinoma.
    Lee EJ; Lee BB; Kim JW; Shim YM; Hoseok I; Han J; Cho EY; Park J; Kim DH
    Eur J Cancer; 2006 May; 42(7):972-80. PubMed ID: 16564166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical evaluation of p53, FHIT, and IGF2 gene expression in esophageal cancer.
    Chava S; Mohan V; Shetty PJ; Manolla ML; Vaidya S; Khan IA; Waseem GL; Boddala P; Ahuja YR; Hasan Q
    Dis Esophagus; 2012 Jan; 25(1):81-7. PubMed ID: 21668571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low expression of FHIT and PTEN correlates with malignancy of gastric carcinomas: tissue-array findings.
    Zheng H; Takahashi H; Murai Y; Cui Z; Nomoto K; Tsuneyama K; Takano Y
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):432-40. PubMed ID: 18091387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicopathological significance of aberrant methylation of the fragile histidine triad gene in patients with hepatocellular carcinoma].
    Sun Y; Geng XP; Zhu LX; Xiong QR; Qian YB; Dong GY; Li XM
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):609-12. PubMed ID: 16784654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of DNA methyltransferase 3b on FHIT expression and DNA methylation of the FHIT promoter region in hepatoma SMMC-7721 cells.
    Wang JX; Zhang YG; Zhao LS
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):273-7. PubMed ID: 19502167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis.
    Gramantieri L; Chieco P; Di Tomaso M; Masi L; Piscaglia F; Brillanti S; Gaiani S; Valgimigli M; Mazziotti A; Bolondi L
    Clin Cancer Res; 1999 Nov; 5(11):3468-75. PubMed ID: 10589760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fragile histidine triad protein expression and correlation with apoptosis in rectal carcinoma].
    Cao J; Xia J; Wang H; DU H; Li WL
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Mar; 10(2):177-81. PubMed ID: 17380463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics analysis of metastasis-related proteins in hepatocellular carcinoma.
    Song PM; Zhang Y; He YF; Bao HM; Luo JH; Liu YK; Yang PY; Chen X
    World J Gastroenterol; 2008 Oct; 14(38):5816-22. PubMed ID: 18855979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of the fragile histidine triad gene in hepatitis C virus-associated hepatocellular carcinoma.
    Zekri AR; Bahnassy AA; Hafez M; El-Shehaby AM; Sherif GM; Khaled HM; Zakhary N
    J Gastroenterol Hepatol; 2005 Jan; 20(1):87-94. PubMed ID: 15610452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implication of mitochondrial involvement in apoptotic activity of fragile histidine triad gene: application of synchronous luminescence spectroscopy.
    Askari MD; Vo-Dinh T
    Biopolymers; 2004 Mar; 73(4):510-23. PubMed ID: 14991669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine induces the fragile histidine triad methylation in human esophageal squamous epithelial cells.
    Soma T; Kaganoi J; Kawabe A; Kondo K; Imamura M; Shimada Y
    Int J Cancer; 2006 Sep; 119(5):1023-7. PubMed ID: 16570269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of fragile histidine triad (FHIT) expression and microsatellite instability in periocular sebaceous gland carcinoma in patients with Muir-Torre syndrome.
    Holbach LM; von Moller A; Decker C; Jünemann AG; Rummelt-Hofmann C; Ballhausen WG
    Am J Ophthalmol; 2002 Jul; 134(1):147-8. PubMed ID: 12095833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Fragile Histidine Triad gene and breast cancer.
    Yang Q; Yoshimura G; Sakurai T; Kakudo K
    Med Sci Monit; 2002 Jul; 8(7):RA140-4. PubMed ID: 12118213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions.
    Hao XP; Willis JE; Pretlow TG; Rao JS; MacLennan GT; Talbot IC; Pretlow TP
    Cancer Res; 2000 Jan; 60(1):18-21. PubMed ID: 10646844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.